A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
| Protocol No. | PHO-COG-ARAR2221 | Scope | National |
|---|---|---|---|
| Principal Investigator | Marissa Just | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | Phase II |
